Industry Research Reports
Global Haemostat Market Insights, Forecast to 2030
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Haemostat market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers:
This report presents an overview of global market for Haemostat, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Haemostat, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Haemostat, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Haemostat sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Haemostat market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Haemostat sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
- Ethicon
- CSL Behring
- Pfizer
- Equimedical BV
- Davol
- Baxter
- Hemcon Medical Technologies
- Ceremed
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Pituitrin
- Hemostatic Sensitivity
- Others
Segment by Application
- Hospital
- Clinic
- ASCs
- Others
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Haemostat in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Haemostat manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Haemostat sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Study Coverage
1.1 Haemostat Product Introduction
1.2 Market by Type
1.2.1 Global Haemostat Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Pituitrin
1.2.3 Hemostatic Sensitivity
1.2.4 Others
1.3 Market by Application
1.3.1 Global Haemostat Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 ASCs
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Haemostat Sales Estimates and Forecasts 2019-2030
2.2 Global Haemostat Revenue by Region
2.2.1 Global Haemostat Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Haemostat Revenue by Region (2019-2024)
2.2.3 Global Haemostat Revenue by Region (2025-2030)
2.2.4 Global Haemostat Revenue Market Share by Region (2019-2030)
2.3 Global Haemostat Sales Estimates and Forecasts 2019-2030
2.4 Global Haemostat Sales by Region
2.4.1 Global Haemostat Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Haemostat Sales by Region (2019-2024)
2.4.3 Global Haemostat Sales by Region (2025-2030)
2.4.4 Global Haemostat Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Haemostat Sales by Manufacturers
3.1.1 Global Haemostat Sales by Manufacturers (2019-2024)
3.1.2 Global Haemostat Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Haemostat in 2023
3.2 Global Haemostat Revenue by Manufacturers
3.2.1 Global Haemostat Revenue by Manufacturers (2019-2024)
3.2.2 Global Haemostat Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Haemostat Revenue in 2023
3.3 Global Key Players of Haemostat, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Haemostat Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Haemostat Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Haemostat, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Haemostat, Product Offered and Application
3.8 Global Key Manufacturers of Haemostat, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Haemostat Sales by Type
4.1.1 Global Haemostat Historical Sales by Type (2019-2024)
4.1.2 Global Haemostat Forecasted Sales by Type (2025-2030)
4.1.3 Global Haemostat Sales Market Share by Type (2019-2030)
4.2 Global Haemostat Revenue by Type
4.2.1 Global Haemostat Historical Revenue by Type (2019-2024)
4.2.2 Global Haemostat Forecasted Revenue by Type (2025-2030)
4.2.3 Global Haemostat Revenue Market Share by Type (2019-2030)
4.3 Global Haemostat Price by Type
4.3.1 Global Haemostat Price by Type (2019-2024)
4.3.2 Global Haemostat Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Haemostat Sales by Application
5.1.1 Global Haemostat Historical Sales by Application (2019-2024)
5.1.2 Global Haemostat Forecasted Sales by Application (2025-2030)
5.1.3 Global Haemostat Sales Market Share by Application (2019-2030)
5.2 Global Haemostat Revenue by Application
5.2.1 Global Haemostat Historical Revenue by Application (2019-2024)
5.2.2 Global Haemostat Forecasted Revenue by Application (2025-2030)
5.2.3 Global Haemostat Revenue Market Share by Application (2019-2030)
5.3 Global Haemostat Price by Application
5.3.1 Global Haemostat Price by Application (2019-2024)
5.3.2 Global Haemostat Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Haemostat Market Size by Type
6.1.1 US & Canada Haemostat Sales by Type (2019-2030)
6.1.2 US & Canada Haemostat Revenue by Type (2019-2030)
6.2 US & Canada Haemostat Market Size by Application
6.2.1 US & Canada Haemostat Sales by Application (2019-2030)
6.2.2 US & Canada Haemostat Revenue by Application (2019-2030)
6.3 US & Canada Haemostat Market Size by Country
6.3.1 US & Canada Haemostat Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Haemostat Sales by Country (2019-2030)
6.3.3 US & Canada Haemostat Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Haemostat Market Size by Type
7.1.1 Europe Haemostat Sales by Type (2019-2030)
7.1.2 Europe Haemostat Revenue by Type (2019-2030)
7.2 Europe Haemostat Market Size by Application
7.2.1 Europe Haemostat Sales by Application (2019-2030)
7.2.2 Europe Haemostat Revenue by Application (2019-2030)
7.3 Europe Haemostat Market Size by Country
7.3.1 Europe Haemostat Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Haemostat Sales by Country (2019-2030)
7.3.3 Europe Haemostat Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Haemostat Market Size
8.1.1 China Haemostat Sales (2019-2030)
8.1.2 China Haemostat Revenue (2019-2030)
8.2 China Haemostat Market Size by Application
8.2.1 China Haemostat Sales by Application (2019-2030)
8.2.2 China Haemostat Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Haemostat Market Size by Type
9.1.1 Asia Haemostat Sales by Type (2019-2030)
9.1.2 Asia Haemostat Revenue by Type (2019-2030)
9.2 Asia Haemostat Market Size by Application
9.2.1 Asia Haemostat Sales by Application (2019-2030)
9.2.2 Asia Haemostat Revenue by Application (2019-2030)
9.3 Asia Haemostat Sales by Region
9.3.1 Asia Haemostat Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Haemostat Revenue by Region (2019-2030)
9.3.3 Asia Haemostat Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Haemostat Market Size by Type
10.1.1 Middle East, Africa and Latin America Haemostat Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Haemostat Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Haemostat Market Size by Application
10.2.1 Middle East, Africa and Latin America Haemostat Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Haemostat Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Haemostat Sales by Country
10.3.1 Middle East, Africa and Latin America Haemostat Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Haemostat Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Haemostat Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Ethicon
11.1.1 Ethicon Company Information
11.1.2 Ethicon Overview
11.1.3 Ethicon Haemostat Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Ethicon Haemostat Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Ethicon Recent Developments
11.2 CSL Behring
11.2.1 CSL Behring Company Information
11.2.2 CSL Behring Overview
11.2.3 CSL Behring Haemostat Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 CSL Behring Haemostat Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CSL Behring Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Haemostat Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Pfizer Haemostat Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Recent Developments
11.4 Equimedical BV
11.4.1 Equimedical BV Company Information
11.4.2 Equimedical BV Overview
11.4.3 Equimedical BV Haemostat Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Equimedical BV Haemostat Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Equimedical BV Recent Developments
11.5 Davol
11.5.1 Davol Company Information
11.5.2 Davol Overview
11.5.3 Davol Haemostat Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Davol Haemostat Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Davol Recent Developments
11.6 Baxter
11.6.1 Baxter Company Information
11.6.2 Baxter Overview
11.6.3 Baxter Haemostat Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Baxter Haemostat Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Baxter Recent Developments
11.7 Hemcon Medical Technologies
11.7.1 Hemcon Medical Technologies Company Information
11.7.2 Hemcon Medical Technologies Overview
11.7.3 Hemcon Medical Technologies Haemostat Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Hemcon Medical Technologies Haemostat Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hemcon Medical Technologies Recent Developments
11.8 Ceremed
11.8.1 Ceremed Company Information
11.8.2 Ceremed Overview
11.8.3 Ceremed Haemostat Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Ceremed Haemostat Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Ceremed Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Haemostat Industry Chain Analysis
12.2 Haemostat Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Haemostat Production Mode & Process
12.4 Haemostat Sales and Marketing
12.4.1 Haemostat Sales Channels
12.4.2 Haemostat Distributors
12.5 Haemostat Customers
13 Market Dynamics
13.1 Haemostat Industry Trends
13.2 Haemostat Market Drivers
13.3 Haemostat Market Challenges
13.4 Haemostat Market Restraints
14 Key Findings in The Global Haemostat Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Haemostat Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Pituitrin
Table 3. Major Manufacturers of Hemostatic Sensitivity
Table 4. Major Manufacturers of Others
Table 5. Global Haemostat Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Haemostat Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 7. Global Haemostat Revenue by Region (2019-2024) & (US$ Million)
Table 8. Global Haemostat Revenue by Region (2025-2030) & (US$ Million)
Table 9. Global Haemostat Revenue Market Share by Region (2019-2024)
Table 10. Global Haemostat Revenue Market Share by Region (2025-2030)
Table 11. Global Haemostat Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 12. Global Haemostat Sales by Region (2019-2024) & (K Units)
Table 13. Global Haemostat Sales by Region (2025-2030) & (K Units)
Table 14. Global Haemostat Sales Market Share by Region (2019-2024)
Table 15. Global Haemostat Sales Market Share by Region (2025-2030)
Table 16. Global Haemostat Sales by Manufacturers (2019-2024) & (K Units)
Table 17. Global Haemostat Sales Share by Manufacturers (2019-2024)
Table 18. Global Haemostat Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 19. Global Haemostat Revenue Share by Manufacturers (2019-2024)
Table 20. Global Key Players of Haemostat, Industry Ranking, 2022 VS 2023 VS 2024
Table 21. Haemostat Price by Manufacturers 2019-2024 (USD/Unit)
Table 22. Global Haemostat Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Haemostat by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Haemostat as of 2023)
Table 24. Global Key Manufacturers of Haemostat, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Haemostat, Product Offered and Application
Table 26. Global Key Manufacturers of Haemostat, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Haemostat Sales by Type (2019-2024) & (K Units)
Table 29. Global Haemostat Sales by Type (2025-2030) & (K Units)
Table 30. Global Haemostat Sales Share by Type (2019-2024)
Table 31. Global Haemostat Sales Share by Type (2025-2030)
Table 32. Global Haemostat Revenue by Type (2019-2024) & (US$ Million)
Table 33. Global Haemostat Revenue by Type (2025-2030) & (US$ Million)
Table 34. Global Haemostat Revenue Share by Type (2019-2024)
Table 35. Global Haemostat Revenue Share by Type (2025-2030)
Table 36. Haemostat Price by Type (2019-2024) & (USD/Unit)
Table 37. Global Haemostat Price Forecast by Type (2025-2030) & (USD/Unit)
Table 38. Global Haemostat Sales by Application (2019-2024) & (K Units)
Table 39. Global Haemostat Sales by Application (2025-2030) & (K Units)
Table 40. Global Haemostat Sales Share by Application (2019-2024)
Table 41. Global Haemostat Sales Share by Application (2025-2030)
Table 42. Global Haemostat Revenue by Application (2019-2024) & (US$ Million)
Table 43. Global Haemostat Revenue by Application (2025-2030) & (US$ Million)
Table 44. Global Haemostat Revenue Share by Application (2019-2024)
Table 45. Global Haemostat Revenue Share by Application (2025-2030)
Table 46. Haemostat Price by Application (2019-2024) & (USD/Unit)
Table 47. Global Haemostat Price Forecast by Application (2025-2030) & (USD/Unit)
Table 48. US & Canada Haemostat Sales by Type (2019-2024) & (K Units)
Table 49. US & Canada Haemostat Sales by Type (2025-2030) & (K Units)
Table 50. US & Canada Haemostat Revenue by Type (2019-2024) & (US$ Million)
Table 51. US & Canada Haemostat Revenue by Type (2025-2030) & (US$ Million)
Table 52. US & Canada Haemostat Sales by Application (2019-2024) & (K Units)
Table 53. US & Canada Haemostat Sales by Application (2025-2030) & (K Units)
Table 54. US & Canada Haemostat Revenue by Application (2019-2024) & (US$ Million)
Table 55. US & Canada Haemostat Revenue by Application (2025-2030) & (US$ Million)
Table 56. US & Canada Haemostat Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 57. US & Canada Haemostat Revenue by Country (2019-2024) & (US$ Million)
Table 58. US & Canada Haemostat Revenue by Country (2025-2030) & (US$ Million)
Table 59. US & Canada Haemostat Sales by Country (2019-2024) & (K Units)
Table 60. US & Canada Haemostat Sales by Country (2025-2030) & (K Units)
Table 61. Europe Haemostat Sales by Type (2019-2024) & (K Units)
Table 62. Europe Haemostat Sales by Type (2025-2030) & (K Units)
Table 63. Europe Haemostat Revenue by Type (2019-2024) & (US$ Million)
Table 64. Europe Haemostat Revenue by Type (2025-2030) & (US$ Million)
Table 65. Europe Haemostat Sales by Application (2019-2024) & (K Units)
Table 66. Europe Haemostat Sales by Application (2025-2030) & (K Units)
Table 67. Europe Haemostat Revenue by Application (2019-2024) & (US$ Million)
Table 68. Europe Haemostat Revenue by Application (2025-2030) & (US$ Million)
Table 69. Europe Haemostat Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 70. Europe Haemostat Revenue by Country (2019-2024) & (US$ Million)
Table 71. Europe Haemostat Revenue by Country (2025-2030) & (US$ Million)
Table 72. Europe Haemostat Sales by Country (2019-2024) & (K Units)
Table 73. Europe Haemostat Sales by Country (2025-2030) & (K Units)
Table 74. China Haemostat Sales by Type (2019-2024) & (K Units)
Table 75. China Haemostat Sales by Type (2025-2030) & (K Units)
Table 76. China Haemostat Revenue by Type (2019-2024) & (US$ Million)
Table 77. China Haemostat Revenue by Type (2025-2030) & (US$ Million)
Table 78. China Haemostat Sales by Application (2019-2024) & (K Units)
Table 79. China Haemostat Sales by Application (2025-2030) & (K Units)
Table 80. China Haemostat Revenue by Application (2019-2024) & (US$ Million)
Table 81. China Haemostat Revenue by Application (2025-2030) & (US$ Million)
Table 82. Asia Haemostat Sales by Type (2019-2024) & (K Units)
Table 83. Asia Haemostat Sales by Type (2025-2030) & (K Units)
Table 84. Asia Haemostat Revenue by Type (2019-2024) & (US$ Million)
Table 85. Asia Haemostat Revenue by Type (2025-2030) & (US$ Million)
Table 86. Asia Haemostat Sales by Application (2019-2024) & (K Units)
Table 87. Asia Haemostat Sales by Application (2025-2030) & (K Units)
Table 88. Asia Haemostat Revenue by Application (2019-2024) & (US$ Million)
Table 89. Asia Haemostat Revenue by Application (2025-2030) & (US$ Million)
Table 90. Asia Haemostat Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 91. Asia Haemostat Revenue by Region (2019-2024) & (US$ Million)
Table 92. Asia Haemostat Revenue by Region (2025-2030) & (US$ Million)
Table 93. Asia Haemostat Sales by Region (2019-2024) & (K Units)
Table 94. Asia Haemostat Sales by Region (2025-2030) & (K Units)
Table 95. Middle East, Africa and Latin America Haemostat Sales by Type (2019-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Haemostat Sales by Type (2025-2030) & (K Units)
Table 97. Middle East, Africa and Latin America Haemostat Revenue by Type (2019-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Haemostat Revenue by Type (2025-2030) & (US$ Million)
Table 99. Middle East, Africa and Latin America Haemostat Sales by Application (2019-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Haemostat Sales by Application (2025-2030) & (K Units)
Table 101. Middle East, Africa and Latin America Haemostat Revenue by Application (2019-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Haemostat Revenue by Application (2025-2030) & (US$ Million)
Table 103. Middle East, Africa and Latin America Haemostat Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 104. Middle East, Africa and Latin America Haemostat Revenue by Country (2019-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Haemostat Revenue by Country (2025-2030) & (US$ Million)
Table 106. Middle East, Africa and Latin America Haemostat Sales by Country (2019-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Haemostat Sales by Country (2025-2030) & (K Units)
Table 108. Ethicon Company Information
Table 109. Ethicon Description and Major Businesses
Table 110. Ethicon Haemostat Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. Ethicon Haemostat Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Ethicon Recent Developments
Table 113. CSL Behring Company Information
Table 114. CSL Behring Description and Major Businesses
Table 115. CSL Behring Haemostat Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. CSL Behring Haemostat Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. CSL Behring Recent Developments
Table 118. Pfizer Company Information
Table 119. Pfizer Description and Major Businesses
Table 120. Pfizer Haemostat Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. Pfizer Haemostat Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Pfizer Recent Developments
Table 123. Equimedical BV Company Information
Table 124. Equimedical BV Description and Major Businesses
Table 125. Equimedical BV Haemostat Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 126. Equimedical BV Haemostat Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Equimedical BV Recent Developments
Table 128. Davol Company Information
Table 129. Davol Description and Major Businesses
Table 130. Davol Haemostat Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 131. Davol Haemostat Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Davol Recent Developments
Table 133. Baxter Company Information
Table 134. Baxter Description and Major Businesses
Table 135. Baxter Haemostat Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 136. Baxter Haemostat Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Baxter Recent Developments
Table 138. Hemcon Medical Technologies Company Information
Table 139. Hemcon Medical Technologies Description and Major Businesses
Table 140. Hemcon Medical Technologies Haemostat Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 141. Hemcon Medical Technologies Haemostat Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Hemcon Medical Technologies Recent Developments
Table 143. Ceremed Company Information
Table 144. Ceremed Description and Major Businesses
Table 145. Ceremed Haemostat Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 146. Ceremed Haemostat Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Ceremed Recent Developments
Table 148. Key Raw Materials Lists
Table 149. Raw Materials Key Suppliers Lists
Table 150. Haemostat Distributors List
Table 151. Haemostat Customers List
Table 152. Haemostat Market Trends
Table 153. Haemostat Market Drivers
Table 154. Haemostat Market Challenges
Table 155. Haemostat Market Restraints
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Haemostat Product Picture
Figure 2. Global Haemostat Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Haemostat Market Share by Type in 2023 & 2030
Figure 4. Pituitrin Product Picture
Figure 5. Hemostatic Sensitivity Product Picture
Figure 6. Others Product Picture
Figure 7. Global Haemostat Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global Haemostat Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Clinic
Figure 11. ASCs
Figure 12. Others
Figure 13. Haemostat Report Years Considered
Figure 14. Global Haemostat Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Haemostat Revenue 2019-2030 (US$ Million)
Figure 16. Global Haemostat Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 17. Global Haemostat Revenue Market Share by Region (2019-2030)
Figure 18. Global Haemostat Sales 2019-2030 ((K Units)
Figure 19. Global Haemostat Sales Market Share by Region (2019-2030)
Figure 20. US & Canada Haemostat Sales YoY (2019-2030) & (K Units)
Figure 21. US & Canada Haemostat Revenue YoY (2019-2030) & (US$ Million)
Figure 22. Europe Haemostat Sales YoY (2019-2030) & (K Units)
Figure 23. Europe Haemostat Revenue YoY (2019-2030) & (US$ Million)
Figure 24. China Haemostat Sales YoY (2019-2030) & (K Units)
Figure 25. China Haemostat Revenue YoY (2019-2030) & (US$ Million)
Figure 26. Asia (excluding China) Haemostat Sales YoY (2019-2030) & (K Units)
Figure 27. Asia (excluding China) Haemostat Revenue YoY (2019-2030) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Haemostat Sales YoY (2019-2030) & (K Units)
Figure 29. Middle East, Africa and Latin America Haemostat Revenue YoY (2019-2030) & (US$ Million)
Figure 30. The Haemostat Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 31. The Top 5 and 10 Largest Manufacturers of Haemostat in the World: Market Share by Haemostat Revenue in 2023
Figure 32. Global Haemostat Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 33. Global Haemostat Sales Market Share by Type (2019-2030)
Figure 34. Global Haemostat Revenue Market Share by Type (2019-2030)
Figure 35. Global Haemostat Sales Market Share by Application (2019-2030)
Figure 36. Global Haemostat Revenue Market Share by Application (2019-2030)
Figure 37. US & Canada Haemostat Sales Market Share by Type (2019-2030)
Figure 38. US & Canada Haemostat Revenue Market Share by Type (2019-2030)
Figure 39. US & Canada Haemostat Sales Market Share by Application (2019-2030)
Figure 40. US & Canada Haemostat Revenue Market Share by Application (2019-2030)
Figure 41. US & Canada Haemostat Revenue Share by Country (2019-2030)
Figure 42. US & Canada Haemostat Sales Share by Country (2019-2030)
Figure 43. U.S. Haemostat Revenue (2019-2030) & (US$ Million)
Figure 44. Canada Haemostat Revenue (2019-2030) & (US$ Million)
Figure 45. Europe Haemostat Sales Market Share by Type (2019-2030)
Figure 46. Europe Haemostat Revenue Market Share by Type (2019-2030)
Figure 47. Europe Haemostat Sales Market Share by Application (2019-2030)
Figure 48. Europe Haemostat Revenue Market Share by Application (2019-2030)
Figure 49. Europe Haemostat Revenue Share by Country (2019-2030)
Figure 50. Europe Haemostat Sales Share by Country (2019-2030)
Figure 51. Germany Haemostat Revenue (2019-2030) & (US$ Million)
Figure 52. France Haemostat Revenue (2019-2030) & (US$ Million)
Figure 53. U.K. Haemostat Revenue (2019-2030) & (US$ Million)
Figure 54. Italy Haemostat Revenue (2019-2030) & (US$ Million)
Figure 55. Russia Haemostat Revenue (2019-2030) & (US$ Million)
Figure 56. China Haemostat Sales Market Share by Type (2019-2030)
Figure 57. China Haemostat Revenue Market Share by Type (2019-2030)
Figure 58. China Haemostat Sales Market Share by Application (2019-2030)
Figure 59. China Haemostat Revenue Market Share by Application (2019-2030)
Figure 60. Asia Haemostat Sales Market Share by Type (2019-2030)
Figure 61. Asia Haemostat Revenue Market Share by Type (2019-2030)
Figure 62. Asia Haemostat Sales Market Share by Application (2019-2030)
Figure 63. Asia Haemostat Revenue Market Share by Application (2019-2030)
Figure 64. Asia Haemostat Revenue Share by Region (2019-2030)
Figure 65. Asia Haemostat Sales Share by Region (2019-2030)
Figure 66. Japan Haemostat Revenue (2019-2030) & (US$ Million)
Figure 67. South Korea Haemostat Revenue (2019-2030) & (US$ Million)
Figure 68. China Taiwan Haemostat Revenue (2019-2030) & (US$ Million)
Figure 69. Southeast Asia Haemostat Revenue (2019-2030) & (US$ Million)
Figure 70. India Haemostat Revenue (2019-2030) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Haemostat Sales Market Share by Type (2019-2030)
Figure 72. Middle East, Africa and Latin America Haemostat Revenue Market Share by Type (2019-2030)
Figure 73. Middle East, Africa and Latin America Haemostat Sales Market Share by Application (2019-2030)
Figure 74. Middle East, Africa and Latin America Haemostat Revenue Market Share by Application (2019-2030)
Figure 75. Middle East, Africa and Latin America Haemostat Revenue Share by Country (2019-2030)
Figure 76. Middle East, Africa and Latin America Haemostat Sales Share by Country (2019-2030)
Figure 77. Brazil Haemostat Revenue (2019-2030) & (US$ Million)
Figure 78. Mexico Haemostat Revenue (2019-2030) & (US$ Million)
Figure 79. Turkey Haemostat Revenue (2019-2030) & (US$ Million)
Figure 80. Israel Haemostat Revenue (2019-2030) & (US$ Million)
Figure 81. GCC Countries Haemostat Revenue (2019-2030) & (US$ Million)
Figure 82. Haemostat Value Chain
Figure 83. Haemostat Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
Related Reports
Global Haemostat Market Research Report 2024
The global Haemostat market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-04
Pages: 82
USD 2900.00
(Single User License)
Haemostat - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Haemostat was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-16
Pages: 98
USD 3950.00
(Single User License)
Global Haemostat Market Research Report 2025
The global market for Haemostat was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-25
Pages: 84
USD 2900.00
(Single User License)
Haemostat- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Haemostat was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 96
USD 3950.00
(Single User License)
Global Haemostat Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Haemostat market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 79
USD 4250.00
(Single User License)
Global Haemostat Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Haemostat market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-30
Pages: 132
USD 4900.00
(Single User License)
Global Haemostat Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Haemostat market is projected to grow from US$ 2150 million in 2025 to US$ 3099 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-05-14
Pages: 177
USD 4900.00
(Single User License)
Global Haemostat Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Haemostat market size was US$ 2150 million in 2025 and is forecast to reach a readjusted size of US$ 3099 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published Date: 2026-05-14
Pages: 150
USD 4250.00
(Single User License)
Haemostat- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Haemostat was estimated to be worth US$ 2150 million in 2025 and is projected to reach US$ 3099 million, growing at a CAGR of 5.4% from 2026 to 2032.
Published Date: 2026-05-14
Pages: 146
USD 3950.00
(Single User License)
Global Haemostat Market Research Report 2026
The global Haemostat market was valued at US$ 2150 million in 2025 and is anticipated to reach US$ 3099 million by 2032, at a CAGR of 5.4% from 2026 to 2032.
Published Date: 2026-05-14
Pages: 134
USD 2900.00
(Single User License)
Global Haemostat Market Research Report 2024
The global Haemostat market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-04
Pages: 82
USD 2900.00 (Single User License)Haemostat - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Haemostat was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-16
Pages: 98
USD 3950.00 (Single User License)Global Haemostat Market Research Report 2025
The global market for Haemostat was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-25
Pages: 84
USD 2900.00 (Single User License)Haemostat- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Haemostat was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 96
USD 3950.00 (Single User License)Global Haemostat Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Haemostat market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 79
USD 4250.00 (Single User License)Global Haemostat Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Haemostat market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-30
Pages: 132
USD 4900.00 (Single User License)Global Haemostat Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Haemostat market is projected to grow from US$ 2150 million in 2025 to US$ 3099 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-05-14
Pages: 177
USD 4900.00 (Single User License)Global Haemostat Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Haemostat market size was US$ 2150 million in 2025 and is forecast to reach a readjusted size of US$ 3099 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published: 2026-05-14
Pages: 150
USD 4250.00 (Single User License)Haemostat- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Haemostat was estimated to be worth US$ 2150 million in 2025 and is projected to reach US$ 3099 million, growing at a CAGR of 5.4% from 2026 to 2032.
Published: 2026-05-14
Pages: 146
USD 3950.00 (Single User License)Global Haemostat Market Research Report 2026
The global Haemostat market was valued at US$ 2150 million in 2025 and is anticipated to reach US$ 3099 million by 2032, at a CAGR of 5.4% from 2026 to 2032.
Published: 2026-05-14
Pages: 134
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
Market Segmentation
Why This Report?
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research